BAIYU HOLDINGS INC (BYU)

US87250W3016 - Common Stock

1.01  -0.49 (-32.67%)

After market: 1.02 +0.01 (+0.99%)

Fundamental Rating

3

Taking everything into account, BYU scores 3 out of 10 in our fundamental rating. BYU was compared to 51 industry peers in the Trading Companies & Distributors industry. The financial health of BYU is average, but there are quite some concerns on its profitability. While showing a medium growth rate, BYU is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year BYU was profitable.
In the past year BYU has reported a negative cash flow from operations.
BYU had negative earnings in 4 of the past 5 years.
BYU had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

BYU has a Return On Assets of 1.63%. This is in the lower half of the industry: BYU underperforms 74.51% of its industry peers.
BYU's Return On Equity of 1.94% is on the low side compared to the rest of the industry. BYU is outperformed by 76.47% of its industry peers.
Industry RankSector Rank
ROA 1.63%
ROE 1.94%
ROIC N/A
ROA(3y)0.23%
ROA(5y)-12.73%
ROE(3y)0.28%
ROE(5y)-24.72%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BYU has a Profit Margin of 6.85%. This is in the better half of the industry: BYU outperforms 60.78% of its industry peers.
The Operating Margin and Gross Margin are not available for BYU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 6.85%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

BYU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BYU has more shares outstanding
The number of shares outstanding for BYU has been increased compared to 5 years ago.
The debt/assets ratio for BYU has been reduced compared to a year ago.

2.2 Solvency

BYU has an Altman-Z score of 1.07. This is a bad value and indicates that BYU is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BYU (1.07) is worse than 84.31% of its industry peers.
BYU has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
BYU has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. BYU outperforms 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACCN/A
WACC6.13%

2.3 Liquidity

BYU has a Current Ratio of 6.77. This indicates that BYU is financially healthy and has no problem in meeting its short term obligations.
BYU's Current ratio of 6.77 is amongst the best of the industry. BYU outperforms 100.00% of its industry peers.
BYU has a Quick Ratio of 6.77. This indicates that BYU is financially healthy and has no problem in meeting its short term obligations.
BYU has a better Quick ratio (6.77) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.77
Quick Ratio 6.77

4

3. Growth

3.1 Past

BYU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 3302.13%, which is quite impressive.
BYU shows a strong growth in Revenue. In the last year, the Revenue has grown by 597.39%.
BYU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 220.19% yearly.
EPS 1Y (TTM)3302.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.97%
Revenue 1Y (TTM)597.39%
Revenue growth 3Y140.48%
Revenue growth 5Y220.19%
Sales Q2Q%458.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.79, which indicates a rather cheap valuation of BYU.
Based on the Price/Earnings ratio, BYU is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of BYU to the average of the S&P500 Index (30.45), we can say BYU is valued rather cheaply.
Industry RankSector Rank
PE 0.79
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BYU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BAIYU HOLDINGS INC

NASDAQ:BYU (9/5/2024, 8:13:59 PM)

After market: 1.02 +0.01 (+0.99%)

1.01

-0.49 (-32.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap50.45M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 0.79
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 1.94%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 6.85%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.77
Quick Ratio 6.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3302.13%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)597.39%
Revenue growth 3Y140.48%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y